Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients-Reference-Cited by-同舟云学术

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

Published:2014-07 Issue: Volume: Page:547
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Konya Hiroyuki,Yano Yuzo,Matsutani Satoshi,Tsunoda Taku,Ikawa Takashi,Kusunoki Yoshiki,Matsuo Toshihiro,Miuchi Masayuki,Katsuno Tomoyuki,Hamaguchi Tomoya,Miyagawa Jun-ichiro,Namba Mitsuyoshi

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies;Diabetes Therapy;2018-02-12

2. Saxagliptin Induces β-Cell Proliferation through Increasing Stromal Cell-Derived Factor-1α In Vivo and In Vitro;Frontiers in Endocrinology;2017-11-27

3. Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension;Expert Opinion on Pharmacotherapy;2017-10-12

4. Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial;Diabetes, Obesity and Metabolism;2017-07-31

5. A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2017-07-06